Correlation Between Abcellera Biologics and Monogram Orthopaedics

Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and Monogram Orthopaedics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and Monogram Orthopaedics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Abcellera Biologics and Monogram Orthopaedics Common, you can compare the effects of market volatilities on Abcellera Biologics and Monogram Orthopaedics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of Monogram Orthopaedics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and Monogram Orthopaedics.

Diversification Opportunities for Abcellera Biologics and Monogram Orthopaedics

0.45

Correlation Coefficient

Abcellera Biologics  Monogram Orthopaedics

Very weak diversification

The 3 months correlation between Abcellera and Monogram is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and Monogram Orthopaedics Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monogram Orthopaedics and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with Monogram Orthopaedics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monogram Orthopaedics has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and Monogram Orthopaedics go up and down completely randomly.

Pair Corralation between Abcellera Biologics and Monogram Orthopaedics

Given the investment horizon of 90 days Abcellera Biologics is expected to under-perform the Monogram Orthopaedics. But the stock apears to be less risky and, when comparing its historical volatility, Abcellera Biologics is 2.04 times less risky than Monogram Orthopaedics. The stock trades about -0.05 of its potential returns per unit of risk. The Monogram Orthopaedics Common is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  1,175  in Monogram Orthopaedics Common on October 25, 2024 and sell it today you would lose (893.00) from holding Monogram Orthopaedics Common or give up 76.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	85.43%
Values	Daily Returns

Abcellera Biologics  vs.  Monogram Orthopaedics Common

Abcellera Biologics

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics disclosed solid returns over the last few months and may actually be approaching a breakup point.

Monogram Orthopaedics

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Monogram Orthopaedics Common are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Monogram Orthopaedics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Abcellera Biologics and Monogram Orthopaedics

The main advantage of trading using opposite Abcellera Biologics and Monogram Orthopaedics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, Monogram Orthopaedics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monogram Orthopaedics will offset losses from the drop in Monogram Orthopaedics' long position.

The idea behind Abcellera Biologics and Monogram Orthopaedics Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.